U.S. FDA Approves Trodelvy® in Pre-treated HR+/HER2- Metastatic Breast Cancer Pharmaceutical Investing
Bristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Conference Pharmaceutical Investing
Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 Dividend Pharmaceutical Investing
Gilead Sciences Announces Fourth Quarter and Full Year 2022 Financial Results Pharmaceutical Investing
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2022 Pharmaceutical Investing
Gilead Awards $7.6 Million in Grants to Advance Health Equity in Breast Cancer Pharmaceutical Investing
AMGEN POSTS FULL TRANSCRIPT AND AUDIO REPLAY OF FOURTH QUARTER AND FULL YEAR 2022 EARNINGS WEBCAST Market News
Kite and Arcellx Close Agreement to Co-develop and Co-commercialize Late-stage Clinical CART-ddBCMA in Multiple Myeloma Pharmaceutical Investing
Aptose Initiates Dosing of Tuspetinib in APTIVATE Expansion Trial in Patients with Acute Myeloid Leukemia Market News
